
Eli Lilly and Company, Akero Therapeutics, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies involved in the healthcare industry, including pharmaceuticals, biotechnology, medical device manufacturers, hospitals, diagnostics, and healthcare services. Investors buy these stocks to gain exposure to developments in medicine and health care delivery, and their value is influenced by factors such as clinical trial results, regulatory approvals, reimbursement policies, and demographic trends. Like other sector investments, medical stocks can offer growth potential but also carry specific risks tied to science and regulation. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Akero Therapeutics (AKRO)
Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients.
Read Our Latest Research Report on AKRO
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read Our Latest Research Report on UNH
Featured Articles
- MarketBeat’s Top Five Stocks to Own in December 2025
- UiPath Surges on Earnings: Should Investors Chase the Momentum?
- Pure Storage’s 27% Fall: Real Opportunity or Deserved Correction?
- Oil Prices May Fall to $55 by 2026—Bad News for This Energy ETF
- 5 High Short-Interest Stocks to Buy Before Q1 2026
- Why These 3 Automotive & Industrial Chip Stocks Just Soared
